vendredi 24 mai 2019

Onco Actu du 24 mai 2019


1. BIOLOGIE



Mapping bone-marrow microenvironment sheds fresh light on leukaemia [Karolinska Institutet]











Genomic, Transcriptomic Analysis Uncovers Molecular Differences Among Liver Cancer Subtypes











1.4 BIOLOGIE - TECHNOS



Studying the function of liver cancer genes in mini-organs [Hubrecht Institute]











4.10 DÉP., DIAG. & PRONO. - FDA, EMA, NICE,...



FDA should pull the plug on thermography [Science-Based Medicine]











4.2 DÉP., DIAG. & PRONO. - GÉNOME



Lack of Knowledge of Natural History of New Biomarkers: The Achilles’ Heel of Precision Health! [Genomics and Precision Health]











Population DNA testing for disease risk is coming. Here are five things to know [The Conversation]











The current state of molecular testing in the treatment of patients with solid tumors, 2019 [CA : A Cancer Journal for Clinicians]










5. TRAITEMENTS



Adding Bevacizumab to Lung Cancer Treatment Results in Modest Overall Survival Benefits, According to Study in JNCCN from Abramson Cancer Center [National Comprehensive Cancer Network]











Allogeneic stem cell transplantation in non-Hodgkin lymphoma: benefit remains unclear [IQWIG]










5.2 PHARMA



Iovance Biotherapeutics Announces Breakthrough Therapy Designation for LN-145 for Treatment of Advanced Cervical Cancer Patients Who Have Progressed on or After Chemotherapy [Iovance]











5.2.3 PHARMA - ÉCONOMIE



Ideaya and Bicycle Therapeutics IPOs Raise $110M for Cancer Drug R&D [Xconomy]











5.3.4 TRAITEMENTS - AMM (FDA, EMA,...)



T-DM1 Approval Expanded to Include Some Women with Early-Stage HER2-Positive Breast Cancer [NCI]










5.5.16 ASCO (MÉDECINE DE PRÉCISION)



Positive Findings from Two TAPUR™ Study Cohorts to Be Presented at 2019 ASCO® Annual Meeting [ASCO]










6.1 OBSERVATION



Black Race Not Associated With Higher Prostate Cancer Death Risk [Prostate Cancer Advisor]










6.10.1 POLITIQUES (USA)



Drug Pricing Bills to Increase Transparency, Lower Out-of-Pocket Costs, Largely Supported by ASCO [ASCO in Action]











Senate Bill to Cut Health Costs, Targets FDA Tweaks [RAPS]











A new Senate health package includes surprisingly aggressive drug pricing reforms [STAT]











6.6 PUBLICATIONS



First Author Should Be Responsible for Paper Accuracy: Study [The Scientist]











Can Twitter, Facebook, and Other Social Media Drive Downloads, Citations? [The Scholarly Kitchen]